Pneumologische Schwerpunktpraxis Lübeck
- Address
- lock Available on a paid plan
Pneumologische Schwerpunktpraxis Lübeck
The Pneumologische Schwerpunktpraxis Lübeck is a specialized pulmonology practice dedicated to advancing treatment options for patients with complex respiratory conditions. The center focuses on cutting-edge research in severe asthma management, particularly investigating novel therapeutic approaches for patients with specific disease phenotypes.
- Severe asthma with eosinophilic phenotype
- Biologic therapy optimization and comparative effectiveness studies
- Advanced anti-IL-5/5R pathway interventions
The practice has established expertise in conducting comparative efficacy trials involving biologics targeting the IL-5 pathway, including next-generation therapies such as depemokimab and established treatments like mepolizumab and benralizumab. Their research contributes to determining optimal treatment strategies for patients with eosinophilic asthma phenotypes who require specialized care beyond standard therapeutic approaches.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pneumologische Schwerpunktpraxis Lübeck
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Non-Inferiority Trial of Depemokimab Versus Mepolizumab or Benralizumab in Severe Eosinophilic Asthma Patients | Glaxosmithkline Research & Development Limited | Phase III | Not Recruiting | May 2021 | Sep 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Benralizumab | 1 | Unknown | 2021-05-28 | 2021-05-28 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.